(FXO) Financials AlphaDEX Fund - Overview
Etf: Financial, Service, Equity, Mid-Cap
Dividends
| Dividend Yield | 1.87% |
| Yield on Cost 5y | 3.21% |
| Yield CAGR 5y | 5.02% |
| Payout Consistency | 93.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.0% |
| Relative Tail Risk | 0.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | -3.14 |
| Character TTM | |
|---|---|
| Beta | 0.945 |
| Beta Downside | 1.075 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.74% |
| CAGR/Max DD | 0.52 |
Description: FXO Financials AlphaDEX Fund January 13, 2026
The First Trust Financials AlphaDEX® Fund (FXO) commits at least 90 % of its net assets-including any investment borrowings-to securities that make up its underlying index. That index is a modified equal-dollar weighted construct that screens the Russell 1000® Financial Services universe using the AlphaDEX® methodology, aiming to capture stocks with the potential to deliver alpha versus conventional passive benchmarks.
Key metrics (as of Q4 2025) show an expense ratio of 0.55 %, assets under management around $2.4 billion, and a 12-month total return of roughly 8.2 % (versus the S&P 500 Financials sector’s 6.9 %). The fund’s performance is closely tied to macro-drivers such as Federal Reserve policy, loan-growth rates, and credit-spread dynamics, which together influence earnings stability across banks, insurers, and diversified financial firms.
If you want a data-rich, side-by-side comparison of FXO’s risk-adjusted performance, ValueRay’s analytics tools can help you dig deeper.
What is the price of FXO shares?
Over the past week, the price has changed by +2.02%, over one month by +0.11%, over three months by +9.32% and over the past year by +11.06%.
Is FXO a buy, sell or hold?
What are the forecasts/targets for the FXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.5 | 11.7% |
FXO Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.14b USD (2.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.14b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.14b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.40% (E(2.14b)/V(2.14b) * Re(9.40%) + (debt-free company))
Discount Rate = 9.40% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)